[Clinical significance of thrombocyte substitutes].
D000017:ABO Blood-Group System; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000707:Anaphylaxis / Q000209:etiology; D000917:Antibody Formation; D001772:Blood Cell Count; D001787:Blood Group Incompatibility; D001791:Blood Platelet Disorders / Q000628:therapy*; D001792:Blood Platelets / Q000276:immunology; D002470:Cell Survival; D004492:Edetic Acid / Q000627:therapeutic use; D006474:Hemorrhagic Disorders / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy; D006801:Humans; D006863:Hydrogen-Ion Concentration; D011696:Purpura, Thrombocytopenic / Q000628:therapy; D012204:Rh-Hr Blood-Group System; D013156:Splenectomy; D013696:Temperature; D013921:Thrombocytopenia / Q000150:complications*; D013997:Time Factors; D065227:Transfusion Reaction
D000017:ABO Blood-Group System; D000305:Adrenal Cortex Hormones; D012204:Rh-Hr Blood-Group System; D004492:Edetic Acid
Klinische Bedeutung des Thrombozytenersatzes.